Author:
Wang Wei,Liang Qi,Nie Wei,Zhang Juan,Chen Cheng
Reference24 articles.
1. FDA. Source Animal, Product, Preclinical, and Clinical Issues Concerning the Use of Xenotransplantation Products in Humans. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research; 2003
2. Onions D, Cooper DK, Alexander TJ, Brown C, Claassen E, Foweraker JE, et al. An approach to the control of disease transmission in pig-to-human xenotransplantation. Xenotransplantation. 2000;7:143-155
3. Blusch JH, Patience C, Martin U. Pig endogenous retroviruses and xenotransplantation. Xenotransplantation. 2002;9:242-251
4. Wood JC, Quinn G, Suling KM, Oldmixon BA, Van Tine BA, Cina R, et al. Identification of exogenous forms of human-tropic porcine endogenous retrovirus in miniature swine. Journal of Virology. 2004;78:2494-2501
5. Public Health US. Service guideline on infectious disease issues in xenotransplantation. Centers for Disease Control and Prevention. MMWR - Recommendations and Reports. 2001;50:1-46
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献